![Page 1: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/1.jpg)
Dawn Kleindorfer, MD
Associate Professor
August 27th, 2008
![Page 2: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/2.jpg)
Financial Disclosures Site Principal Investigator, PRoFESS
study, 2004-2008
Speaker’s Bureau, Boehringer IngelheimNon-significant category, per UC guidelines
Member, National Stroke Experts Advisory Panel, Boehringer Ingelheim, 8/08
![Page 3: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/3.jpg)
![Page 4: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/4.jpg)
![Page 5: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/5.jpg)
![Page 6: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/6.jpg)
![Page 7: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/7.jpg)
![Page 8: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/8.jpg)
![Page 9: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/9.jpg)
![Page 10: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/10.jpg)
![Page 11: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/11.jpg)
![Page 12: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/12.jpg)
![Page 13: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/13.jpg)
![Page 14: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/14.jpg)
![Page 15: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/15.jpg)
![Page 16: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/16.jpg)
![Page 17: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/17.jpg)
![Page 18: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/18.jpg)
![Page 19: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/19.jpg)
![Page 20: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/20.jpg)
![Page 21: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/21.jpg)
![Page 22: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/22.jpg)
![Page 23: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/23.jpg)
![Page 24: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/24.jpg)
Discussion Cases
65yo BF, with HTN, presents with her first ischemic stroke, small vessel subtype.Which antiplatelet at discharge?
72yo WM c HTN, DM, HLD, smoking, presents with his second ischemic stroke, R MCA infarct, on aspirinWhich antiplatelet at discharge?
![Page 25: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/25.jpg)
Bottom Line for Stroke Prevention? Still will be controversial as to which anti-
platelet is first line
PRoFESS showed that aggrenox and plavix are equally effective and both are options
Previous data had shown aggrenox is better than aspirin, and more controversially, that plavix is better than aspirin, PRoFESS doesn’t change that
![Page 26: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/26.jpg)
Bottom Line?
Issues such as patient compliance, financial situation, history of headaches, may need to be factored in for each patient
Don’t forget other risk factors! May make a much larger impact than agonizing over antiplatelets….
![Page 27: Dawn Kleindorfer, MD Associate Professor August 27 th, 2008](https://reader035.vdocuments.net/reader035/viewer/2022062803/56649efe5503460f94c13208/html5/thumbnails/27.jpg)